Hypothyroidism and Dyshormonogenesis Induced by D-Penicillamine in Children with Wilson's Disease and Healthy Infants Born to a Mother with Wilson's Disease

被引:8
|
作者
Hanukoglu, Aaron [1 ,4 ]
Curiel, Batya [1 ,4 ]
Berkowitz, Drora [5 ]
Levine, Arieh [2 ,4 ]
Sack, Joseph [6 ]
Lorberboym, Mordehai [3 ,4 ]
机构
[1] E Wolfson Med Ctr, Div Pediat Endocrinol, IL-58100 Holon, Israel
[2] E Wolfson Med Ctr, Div Pediat Gastroenterol, IL-58100 Holon, Israel
[3] E Wolfson Med Ctr, Inst Nucl Med, IL-58100 Holon, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Haifa, Israel
[5] Rambam Med Ctr, Haifa, Israel
[6] Minist Hlth, Jerusalem, Israel
来源
JOURNAL OF PEDIATRICS | 2008年 / 153卷 / 06期
关键词
D O I
10.1016/j.jpeds.2008.06.015
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Two siblings born to a mother with Wilson's disease, who was taking D-penicillamine, developed transient goitrous hypothyroidism. A prospective evaluation of 5 patients with Wilson's disease taking and not talking D-penicillamine for as long as 9.5 years showed subclinical hypothyroidism. D-penicillamine probably inhibited thyroperoxidase activity in utero in healthy infants and during childhood in patients with Wilson's disease. (J Pediatr 2008.153:864-6)
引用
收藏
页码:864 / 866
页数:3
相关论文
共 50 条
  • [31] Evaluation of vitamin B6 supplementation in Wilson's disease patients treated with D-penicillamine
    Mbala, Justin
    Belmalih, Abdelouahed
    Guillaud, Olivier
    Lachaux, Alain
    Bedoya, Eduardo Couchonnal
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [32] Concurrent administration of D-penicillamine and zinc on copper excretion in the rat: a potential treatment for Wilson's disease?
    Gomez, M
    Domingo, JL
    Jones, MM
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 5, 1998, 5 : 636 - 640
  • [33] Cooper-deficiency myeloneuropathy in Wilson's Disease as a result of D-penicillamine treatment: A case report
    Gomes, A.
    Rolim, F.
    Menezes, K.
    Brito, L.
    Moura, A.
    Lima, J.
    Marinho, A.
    Ferreira, G.
    Carvalho, F.
    MOVEMENT DISORDERS, 2020, 35 : S570 - S571
  • [34] Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease
    Chen, Yuting
    Qiu, Yangyang
    Chen, Meiqing
    Jiang, Ying
    Qiu, Xiaoyan
    Gao, Lujuan
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (01) : 126 - 130
  • [35] Relapse following withdrawal of D-penicillamine from combination (D-penicillamine plus zinc) therapy in hepatic Wilson disease
    Panda, Kalpana
    Lal, Bikrant B.
    Sood, Vikrant
    Khanna, Rajeev
    Alam, Seema
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (05): : 1017 - 1026
  • [36] Adverse Events with d-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit
    Kumar, Sanjay
    Patra, Biswa Ranjan
    Irtaza, Mohammed
    Rao, Praveen Kumar
    Giri, Suprabhat
    Darak, Harish
    Gopan, Amrit
    Kale, Aditya
    Shukla, Akash
    CLINICAL DRUG INVESTIGATION, 2022, 42 (02) : 177 - 184
  • [37] Urinary copper excretion before and after oral intake of D-penicillamine in parents of patients with Wilson's disease
    Vieira, Jakeliny
    Oliveira, Pedro Vitoriano
    Juliano, Vara
    Jorge Warde, Karim Repsold
    Deguti, Marta Mitiko
    Barbosa, Egberto Reis
    Carrilho, Flair Jose
    Rachid Cancado, Eduardo Luiz
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (04) : 323 - 327
  • [38] Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease
    Atzori, Laura
    Ferreli, Caterina
    Agosta, Daniele
    Mou, Marzia
    Coni, Pierpaolo
    Lachowicz, Joanna Izabela
    Pilloni, Luca
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (02) : 246 - 249
  • [39] Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit
    Sanjay Kumar
    Biswa Ranjan Patra
    Mohammed Irtaza
    Praveen Kumar Rao
    Suprabhat Giri
    Harish Darak
    Amrit Gopan
    Aditya Kale
    Akash Shukla
    Clinical Drug Investigation, 2022, 42 : 177 - 184
  • [40] Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion
    Fukuoka, N
    Morita, S
    Hamatani, S
    Okada, H
    Kondoh, M
    Imai, T
    Ohnishi, S
    Itoh, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2002, 122 (08): : 585 - 588